MX2018005456A - Capsulas de liberación prolongada recubiertas con película. - Google Patents

Capsulas de liberación prolongada recubiertas con película.

Info

Publication number
MX2018005456A
MX2018005456A MX2018005456A MX2018005456A MX2018005456A MX 2018005456 A MX2018005456 A MX 2018005456A MX 2018005456 A MX2018005456 A MX 2018005456A MX 2018005456 A MX2018005456 A MX 2018005456A MX 2018005456 A MX2018005456 A MX 2018005456A
Authority
MX
Mexico
Prior art keywords
extended release
release film
capsules
coated capsules
hard
Prior art date
Application number
MX2018005456A
Other languages
English (en)
Inventor
Mcguffy Irena
M Bell William
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of MX2018005456A publication Critical patent/MX2018005456A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen formulaciones farmaceuticas, preferiblemente en forma de capsulas de cubierta blanda o capsulas de cubierta dura, que presentan una liberación prolongada mediante el uso de un recubrimiento que comprende un polimero insoluble en agua y un formador de poros independiente del pH. La liberacion prolongada de capsulas de cubierta blanda y capsulas de cubierta dura se puede lograr sin el uso de materiales semistilidos o solidos a base de lipidos.
MX2018005456A 2015-10-30 2016-10-27 Capsulas de liberación prolongada recubiertas con película. MX2018005456A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/928,029 US20170119680A1 (en) 2015-10-30 2015-10-30 Extended release film-coated capsules
PCT/US2016/059116 WO2017075215A1 (en) 2015-10-30 2016-10-27 Extended release film-coated capsules

Publications (1)

Publication Number Publication Date
MX2018005456A true MX2018005456A (es) 2018-11-09

Family

ID=57233954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005456A MX2018005456A (es) 2015-10-30 2016-10-27 Capsulas de liberación prolongada recubiertas con película.

Country Status (10)

Country Link
US (1) US20170119680A1 (es)
EP (1) EP3368019A1 (es)
JP (1) JP2018531985A (es)
CN (1) CN108601743A (es)
AU (1) AU2016344402A1 (es)
BR (1) BR112018008617A2 (es)
CA (1) CA3003644A1 (es)
HK (1) HK1253677A1 (es)
MX (1) MX2018005456A (es)
WO (1) WO2017075215A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020044121A1 (en) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Oral formulations of phenylalanine and cannabinoids
CA3111272A1 (en) 2018-09-05 2020-03-12 Renapharma AB An iron containing composition and use thereof
CN114072138A (zh) * 2019-06-03 2022-02-18 R.P.谢勒技术有限公司 延迟释放软凝胶胶囊
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
JP2023518245A (ja) * 2020-03-18 2023-04-28 アール．ピー．シェーラー テクノロジーズ，エルエルシー ソフトゲルカプセル
MX2022015160A (es) * 2020-06-02 2023-01-16 Scherer Technologies Llc R P Capsulas de gelatina blanda de liberacion retardada.
US20230390210A1 (en) * 2020-10-16 2023-12-07 R.P. Scherer Technologies, Llc Modified release softgel capsules
CA3224069A1 (en) * 2021-07-06 2023-01-12 Karunakar Sukuru Softgel capsule

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK164642C (da) 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
IT1245891B (it) 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US6204243B1 (en) * 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6352719B1 (en) 1998-11-11 2002-03-05 Bioprogress Technology International, Inc. Capsule based drug delivery system
CN1161101C (zh) 1998-12-17 2004-08-11 阿尔扎有限公司 用多层包衣将填充液体的明胶胶囊转变成控制释放的系统
US20020114832A1 (en) 2000-12-11 2002-08-22 Dr. Willmar Schwabe Gmbh & Co. Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form
US20030003144A1 (en) 2001-05-01 2003-01-02 Keller Brian C. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030092765A1 (en) 2001-11-15 2003-05-15 John Kelly Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
DE60327807D1 (de) 2002-03-26 2009-07-09 Euro Celtique Sa Gelbeschichtete zusammensetzungen mit verzögerter freisetzung
FR2838349B1 (fr) 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US20040224020A1 (en) 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
KR20060003350A (ko) * 2003-04-14 2006-01-10 에프엠씨 코포레이션 균질한 열가역성 알기네이트 필름 및 이로부터 제조된 연질캡슐
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
WO2005097082A1 (en) 2004-03-31 2005-10-20 Bpsi Holdings, Inc. Enteric coatings for orally ingestible substrates
CA2581775A1 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Dihydropyrimidine microcapsule - formulations
US20090017110A1 (en) 2005-05-31 2009-01-15 Capricorn Pharma Inc. Modified release formulations of anti-irritability drugs
US20070082046A1 (en) 2005-10-11 2007-04-12 Banner Pharmacaps, Inc. Enteric valproic acid
JP5628480B2 (ja) 2006-03-09 2014-11-19 グラクソスミスクライン エルエルシー 医薬成分を含有するコーティングカプセル
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US20080187579A1 (en) * 2007-02-01 2008-08-07 Pavan Bhat Extended-release dosage form
CN101049380A (zh) * 2007-05-11 2007-10-10 张冰文 含有山茶油的肠溶软胶囊及其制备方法
US20090136650A1 (en) 2007-09-18 2009-05-28 Viva Pharmaceuticals Inc. Enteric coatings for orally ingestible compositions
WO2010042499A1 (en) 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
US20100291201A1 (en) 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
CN103169685B (zh) * 2011-12-23 2018-03-06 石药集团中奇制药技术（石家庄）有限公司 一种丁苯酞控释制剂及其制备方法
EP3041463A1 (en) * 2013-09-02 2016-07-13 Sun Pharmaceutical Industries Ltd Pulsatile-release dosage form

Also Published As

Publication number Publication date
EP3368019A1 (en) 2018-09-05
HK1253677A1 (zh) 2019-06-28
US20170119680A1 (en) 2017-05-04
CN108601743A (zh) 2018-09-28
JP2018531985A (ja) 2018-11-01
BR112018008617A2 (pt) 2018-10-30
CA3003644A1 (en) 2017-05-04
AU2016344402A1 (en) 2018-05-17
WO2017075215A1 (en) 2017-05-04

Similar Documents

Publication Publication Date Title
MX2018005456A (es) Capsulas de liberación prolongada recubiertas con película.
RS60284B1 (sr) Supstituisani indazoli, postupak za njihovo dobijanje, farmaceutski preparati, koji ih sadrže, kao i njihova upotreba za proizvodnju lekova
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
MX2016014320A (es) Composiciones de suspension de liberacion prolongada.
IL252324B (en) Solid dispersion containing arn-509 and poly(meth)acrylate polymer, particles and pharmaceutical preparation containing them, methods for their preparation and their uses
IL272638A (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
PH12016501841A1 (en) Immunosuppressant formulation
HK1256674A1 (zh) 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途
EP3175847A4 (en) Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties
IL252897A0 (en) Indanyl compounds, pharmaceutical preparations and their medical uses
IL273339A (en) Griseofulbin compound and its medical use
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
IL290114A (en) Pharmaceutical preparations, their preparation and uses
EP3313187A4 (en) FORMULATION WITH DELAYED RELEASE AND TABLETS MANUFACTURED THEREFROM
ZA201806766B (en) Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
MX2016015261A (es) Dispersion solida de allisartan isoproxilo y su composicion.
EP3388433A4 (en) PHTHALAZINE DERIVATIVE AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3263107A4 (en) Block copolymer conjugate of physiologically active substance
PL3229843T3 (pl) Kompozycja farmaceutyczna, wytwarzanie i zastosowanie tej kompozycji
MX2016017142A (es) Dispersion solida de allisartan isoproxilo y composicion farmaceutica que comprende la misma.
IL265677A (en) Formulation of a controlled-release ophthalmic drug and its uses
IL249860A0 (en) Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer
EP3733176A4 (en) COMPOSITION CONSISTING OF PIPERACILLIN, ITS PHARMACEUTICAL PREPARATION AND ITS USE
EP3310786A4 (en) Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
EP3258956A4 (en) Dldh, derivatives thereof and formulations comprising same for use in medicine